We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proteome Sciences Plc | LSE:PRM | London | Ordinary Share | GB0003104196 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | 2.30 | 3.00 | - | 0.00 | 13:55:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 5.03M | -2.44M | -0.0083 | -3.19 | 7.82M |
Date | Subject | Author | Discuss |
---|---|---|---|
14/11/2024 19:30 | 93197 see 93196 re 93195 Pwned permanently. | barry evans | |
14/11/2024 18:46 | Why not Peverill. Anyone can work hard - even if for no results. | goatherd | |
14/11/2024 18:01 | But not for shareholders. | peverill | |
14/11/2024 10:55 | By working very hard. And, just perhaps, very successfully. At least in the eyes of his employers. | goatherd | |
14/11/2024 07:37 | How has Pike made such a good living from a company that doesn't make any money.??? | peverill | |
12/11/2024 15:57 | I'm OK thanks little black bird. I am bubbling over with Proline. | dominiccummings | |
12/11/2024 13:06 | Harking back to the title of the thread, for any that remember the significance, here is an excellent video explaining up-to-date understanding of tau-protein and prion assemblies in the development of AD. (Dom, we fully understand if you just pretend to watch it). Well ahead of their time as usual, it seems PRM were correct in focussing on the prion-tau relationship and similarities in their AD research. Whether any of their understanding can ever be monetised is, as they say, another matter, As they also say, we shall see. | small crow | |
07/11/2024 14:21 | PRM IP infringement alert! Arlington Chetwynd Talbott7 Nov '24 - 14:05 - 29347 of 29347 0 0 0 Can everyone just calm down?.....KEFI is all about finding something else to do while you wait. | elpirata | |
06/11/2024 18:03 | Good to see almost every worldwide stock has had a positive bounce...apart from Prm of course. Even Trump looks like a saint compared to Pearce. | canaletto | |
01/11/2024 11:18 | Sooner it's over the better ;-) | peverill | |
01/11/2024 11:08 | Doesnt time fly, CJP now in his 70's, Pike, Diggle & NED's 60's, how much longer has this got? | elpirata | |
31/10/2024 15:54 | Pools and facts,don't make me laugh. | peverill | |
31/10/2024 14:46 | w41, Wrong! I know this for a fact. | pools2 | |
31/10/2024 14:28 | pools2 - firstly you can’t possibly know the reason. Secondly she is ‘walking away’ (factually correct) whatever the reason or the connotation! W41 | wrighty41 | |
31/10/2024 13:14 | Can hardly be viewed as any great loss. The performance has been abysmal and as a result share price is in the doldrums. That happened under her watch. | monte1 | |
31/10/2024 12:55 | The CEO is not 'walking away' as you put it, with the negative connotations that implies! Mariola's husband is much older than her and she is simply retiring (as any wealthy person would) to be with him and enjoy the time they have left together. | pools2 | |
31/10/2024 11:21 | The commercial progress PRM have made this year has been very disappointing & has resulted in yet another CEO ‘walking away’. I was hoping for a 6p share price by y/e 2024 but that now seems to have been wildly optimistic! W41 | wrighty41 | |
31/10/2024 08:28 | Revolutionizing Mass Spec: New Study Highlights TMTpro 35-plex for Higher Throughput The TMTpro 35-plex reagents represent a significant advancement in sample multiplexing, offering higher throughput, reduced missing values, and seamless integration with existing workflows. | pools2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions